Clinical trial
A Randomized, Open Label, Phase IV, Multicenter Study for Efficacy and Safety of Lamivudine Versus Entecarvir Therapy in HBV-related Advanced Liver Disease Patients With High Viral Load and Normal or Slightly Elevated Transaminase
NCT00823550 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open Label, Phase IV, Multicenter Study for Efficacy and Safety of Lamivudine Versus Entecarvir Therapy in HBV-related Advanced Liver Disease Patients With High Viral Load and Normal or Slightly Elevated Transaminase
- Lead sponsor
- Yonsei University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2009
- Completion date
- July 31, 2015
- Enrollment
- 462 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.